What are the latest figures on the influenza diagnostic market’s size and projected CAGR?
The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.73 billion in 2024 to $2.89 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to e-commerce growth, labor shortages, automation and productivity, supply chain optimization, rising costs of labor, government support for automation and robotics.
The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to customization and scalability, environmental and sustainability goals, need to improve operational efficiency, need to meet the demands of modern supply chain dynamics. Major trends in the forecast period include advanced technology integration, robotic picking and packing, autonomous mobile robots, real-time data and analytics, ai-driven decision making, collaborative robots, advancements in robotic technology.
Get Your Free Sample of The Global Influenza Diagnostic Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp
Which Market drivers have played a significant role in driving the influenza diagnostic market?
Rapid diagnostic tests are expected to propel the growth of the influenza diagnostic market going forward. Diagnostic tests are medical procedures or tools used to confirm or rule out a condition or disease. Rapid diagnostic tests (RDTs) are increasing due to their growing demand for quick, accurate results in healthcare. Rapid influenza diagnostic tests (RIDTs) can detect influenza viral antigens in 10-15 minutes with moderate sensitivity (50-70%). For instance, in July 2024, according to the Australian Institute of Health and Welfare, a Australia-based government agency for the information on the health and diseases, the volume of diagnostic imaging services rose from 28.4 million in 2021–22 to 29.7 million in 2022–23. Thus, rapid diagnostic tests are driving the growth of the influenza diagnostic market.
What are the key segments within the influenza diagnostic market?
The influenza diagnostic market covered in this report is segmented –
1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users
Subsegments:
1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)
2) By Viral Culture: Cell Culture, Egg-based Culture
3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining
4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay
5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report
Which key players are shaping the influenza diagnostic market?
Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.
Which transformative trends will shape the influenza diagnostic market landscape?
Major companies operating in the influenza diagnostic market are developing innovative products such as Lucira COVID-19 & Flu Home Test for the simultaneous rapid qualitative detection. The Lucira COVID-19 and Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes. For instance, in February 2023, Pfizer Inc., a US-based pharmaceutical company received approval for the Lucira COVID-19 & Flu Home Test. The test can detect influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus that causes COVID-19.
How do regional factors impact the influenza diagnostic market, and which region is the largest contributor?
North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Influenza Diagnostic Market Report 2025 Offer?
The influenza diagnostic market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
